Global /South Korea /Healthcare /Drug Manufacturers - General /058820

CMG Pharmaceutical Co., Ltd.

058820

• KRX: 058820 • Delayed

1,774KRW -1.7%

1.14 USD

As of 7 June 2026, CMG Pharmaceutical Co., Ltd. has a market cap of $174.0M USD, ranking #21932 globally and #887 in South Korea. It ranks #1977 in the Healthcare sector, and #712 in the Drug Manufacturers - General industry.

Global Rank

21932

Country Rank

887

Sector Rank

1977

Industry Rank

712

Key Stats

Market Cap

$174.0MUSD

266.71B KRW

Enterprise Value

$200.14MUSD

312.21B KRW

Revenue (TTM)

$68.65MUSD

105.23B KRW

EBITDA (TTM)

-$391.31KUSD

-610.42M KRW

Net Income (TTM)

-$6.57MUSD

-10.08B KRW

EBITDA Margin

-0.6%

Profit Margin

-9.6%

PS Ratio

2.5

PB Ratio

1.3

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Joohyung Lee open_in_new

Employees

223

Founded

2001

Website

cmgpharma.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.7%	1.6%	-3.9%	-11%	-4%	-2.9%	-29%	-16%	-60%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	058820 (주)CMG제약 ISIN: KR7058820002 Shares Out.: Shares Outstanding: 147.842M¹ Shares Float: 111.955M² TV: TradingView: KRX: 058820 SA: Stock Analysis: KRX: 058820 YF: Yahoo Finance: 058820.KS GF: Google Finance: KRX: 058820 BA: Barron's: 058820 MS: Morningstar: XKRX: 058820	1,774 KRW	TV: TradingView: KRX: 058820 SA: Stock Analysis: KRX: 058820 YF: Yahoo Finance: 058820.KS GF: Google Finance: KRX: 058820 BA: Barron's: 058820 MS: Morningstar: XKRX: 058820

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About CMG Pharmaceutical Co., Ltd.

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.07B 13.91T KRW 5K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.72B 10.3T KRW 4K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.2B 7.97T KRW 3K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.92B 7.55T KRW 3K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.51B 6.92T KRW 2K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.41B 6.76T KRW 2K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 438K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 314K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 207K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 186K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 166K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 159K%	20.5	Switzerland

chevron_leftBack